SV8 Biotech Fund LP
SV8 Biotech Fund LP is a venture capital fund based in London, United Kingdom. According to its most recent Form D, filed Jun 29, 2026, it has sold $70,000,000 of interests to 3 investors since its first sale in Dec 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include James Costine; Kate Bingham; SV Health Managers LLP.
- Total raised
- $70,000,000Cumulative sales reported on Form D
- Investors
- 3
- First sale
- Dec 16, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- James Costine; Kate Bingham; SV Health Managers LLP
- Latest Form D
- Jun 29, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about SV8 Biotech Fund LP
What is the minimum investment for SV8 Biotech Fund LP?
SV8 Biotech Fund LP's latest Form D, filed Jun 29, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in SV8 Biotech Fund LP?
SV8 Biotech Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has SV8 Biotech Fund LP raised?
SV8 Biotech Fund LP reports $70,000,000 sold from 3 investors on its Form D filed Jun 29, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is SV8 Biotech Fund LP based?
SV8 Biotech Fund LP is based in London, United Kingdom and is managed by SV Health Managers LLP.
When did SV8 Biotech Fund LP launch?
SV8 Biotech Fund LP reports its first sale in Dec 2025.
Size compared with every venture capital fund
Raised more than 74% of the 39 venture capital funds based in United Kingdom, and more than 97% of all 15,160 that report sales.